Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
PGE stock offering and forward sale agreement
The stock is listed on the NYSE
Recursion Pharmaceuticals $150 million private placement
We advised the placement agents on the private placement of common stock
Fifth Third Bancorp $1 billion senior notes offering
The investment-grade notes are due 2028
Fifth Third Bank $1 billion senior notes offering
The investment-grade notes are due 2025
ADT $1.2 billion cash tender offer for stock
The company’s shares are traded on the NYSE
DFZQ $300 million bonds offering
The investment-grade bonds are due 2025
Prime Medicine $175 million IPO
The shares are listed on the Nasdaq Global Market
RXO $355 million notes offering
The notes are being offering in connection with the intended spinoff of RXO
Denali Therapeutics $316 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Diageo Capital $2 billion notes offering
The investment-grade notes are due 2025, 2027 and 2033